Filipin
|
Filipin III chemical structure | |
| [3R-[3R*(R*),4S*,6S*,8S*,10R*,12R*,14R*,16S*,17E,19E,21E,23E,25E,27S*,28R*]]-4,6,8,10,12,14,16,27-Octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethyloxacyclooctacosa-17,19,21,23,25-pentaen-2-one | |
| CAS number 480-49-9 |
Other Names Oxacyclooctacosane; 14-Deoxylagosin; 15-Deoxylagosin; Filimarisin |
| Chemical formula | C35H58O11 |
| Molecular weight | 654.83 |
|
WikiDoc Resources for Filipin |
|
Articles |
|---|
|
Most recent articles on Filipin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Filipin at Clinical Trials.gov Clinical Trials on Filipin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Filipin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Filipin Risk calculators and risk factors for Filipin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Filipin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Filipin was isolated by chemists at the Upjohn company in 1955 from the mycelium and culture filtrates of a previously unknown actinomycete, Streptomyces filipinensis, that was discovered in a soil sample collected in the Philippine Islands. Thus the name Filipin. The isolate possessed potent antifungal activity. It was identified as a polyene macrolide based on its characteristic UV-Vis and IR spectra.
Functions
Although the polyene macrolide antibiotics exhibit potent antifungal activity, most are too toxic for therapeutic applications, with the exceptions of amphotericin B and nystatin A1. Unlike amphotericin B and nystatin A1 which form sterol-dependent ion channels, filipin is thought to be a simple membrane disrupter. Since Filipin is highly fluorescent and binds specifically to cholesterol it has found widespread use as a histochemical stain for cholesterol. This method of detecting cholesterol in cell membranes is used clinically in the study and diagnosis of Type C Niemann-Pick disease.
It is also used in cellular biology as an inhibitor of the raft/caveolae endocytosis pathway on mamallian cells (at concentrations around 3 µg/mL)
Types
Filipin is a mixture of four components - filipin I (4%), II (25%), III (53%), and IV (18%) - and should be referred to as the filipin complex.
- The major component, filipin III, has the structure which was proposed by Ceder and Ryhage for the filipin complex.
- Filipin I, which has been difficult to characterize, is probably a mixture of several components each having two hydroxyl groups fewer than filipin III.
- Mass spectroscopy and NMR data indicate that Filipin II is 1'-deoxy-filipin III.
- Filipin IV is isomeric to filipin III. Their NMR spectra are nearly identical with the major difference being the splitting pattern of the proton at C2. This indicates that filipin IV is probably epimeric to filipin III at either C1' or C3.
The relative and absolute stereochemistry of filipin III was determined by 13C NMR acetonide analysis.
References
- Whitfield, G. B.; Brock, T. D.; Ammann, A.; Gottlieb, D.; Carter, H. E. (1955). "Filipin, an Antifungal Antibiotic: Isolation and Properties". J. Am. Chem. Soc. 77: 4799–4801.
- Ceder, O.; Ryhage, R. (1964). "The Structure of Filipin". Acta Chem. Scand. 18: 558–561.
- Bergy, M. E.; Eble, T. E. (1968). "Filipin Complex". Biochem. 7: 653–659.
- Rychnovsky, S. D.; Richardson, T. I. (1995). "Relative and Absolute Configuration of Filipin III". Angew. Chem., Int. Ed. Engl. 34: 1227–1230.
External links
- Filipin at the US National Library of Medicine Medical Subject Headings (MeSH)